4//SEC Filing
Dhaliwal Harpreet S. 4
Accession 0001209191-22-016523
CIK 0001649094other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:54 PM ET
Size
7.4 KB
Accession
0001209191-22-016523
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Transactions
- Award
Common Stock
2022-03-02+17,500→ 17,500 total - Award
Stock Option (right to buy)
2022-03-02+45,000→ 45,000 totalExercise: $24.79Exp: 2032-03-01→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
- [F2]1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001886794
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:54 PM ET
- Size
- 7.4 KB